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Fatal cases of filoviral infection are accompanied by a marked immunosuppression. Endothelial cells play a vital role in the
host immune response through the expression of several immunomodulatory genes in addition to the expression of the
antiviral genes, 29,59-oligoadenylate synthetase [29-59(A)N], and the double-stranded RNA (dsRNA)-activated protein kinase
(PKR). dsRNA, an intermediate generated during viral replication and gene transcription of many viruses, leads to the
induction of immunomodulatory genes in endothelial cells. In this report, we show that induction of the major histocompat-
ibility complex class I family of genes, 29-59(A)N, interleukin-6 (IL-6), PKR, interferon (IFN)-regulatory factor-1, and intercellular
adhesion molecule-1 (ICAM-1) by dsRNA in human umbilical vein endothelial cells is suppressed by infection with the
filovirus Ebola–Zaire (EZ). In contrast, induction of IL-6 and ICAM-1 by IL-1 is intact in EZ-infected cells. Gel shift analysis
demonstrates that dsRNA-induced protein binding to IFN-responsive elements is strongly suppressed by EZ-IFN, whereas
NF-kB activation by dsRNA remains intact. We previously reported that IFN signaling is suppressed by EZ infection, and these
data strongly suggest that elements shared between IFN and dsRNA signaling are being inhibited by EZ. Inhibition of IFN and
dsRNA responsiveness could play a role in the immunosuppression seen in EZ infections and would play a role in the
pathogenesis of disease caused by EZ. © 1998 Academic Press
INTRODUCTION
Ebola–Zaire (EZ) is an enveloped, negative-stranded
RNA virus with a nonsegmented genome belonging to
the family Filoviridae in the order Mononegavirales. In-
fection with EZ results in a fulminating, febrile, hemor-
rhagic disease with a mortality rate between 80% and
90% in humans and other higher primates. The most
striking observation in patients with fatal filoviral infec-
tions is that they die with very high viremia and little
mononuclear phagocytic infiltration into sites of infection
and little evidence of a humoral or cell-mediated re-
sponse (Peters et al., 1996).
Among the cell types that are heavily infected by EZ
are endothelial cells (Geisbert et al., 1992; Georges-
Courbot et al., 1997). Endothelial cells play an impor-
tant role in the host antiviral response through the
expression of a number of immunomodulatory genes
that are induced by viruses or cytokines (Dianzani and
Malavasi, 1995; Ruszczak and Schwartz, 1996). It is
thought that viral induction of an antiviral state is in
part mediated through double-stranded (ds)RNA spe-
cies generated during viral replication or transcription
(Carter and De Clercq, 1974; Field et al., 1967). In
endothelial cells, dsRNA induces many immunomodu-
latory genes, such as cellular adhesion molecules
(Doukas et al., 1994; Yang et al., 1994), major histo-
compatibility complex class (MHC) I (Doukas et al.,
1994), and interleukin (IL)-6 (Doukas et al., 1994; Yang
et al., 1994). dsRNA also induces and activates two
antiviral proteins in the cell, 29-59-(A)N and the dsRNA-
activated protein kinase (PKR), both of which inhibit
protein synthesis through different mechanisms (for
review, see Jacobs and Langland, 1996). Recently, it
has been shown that dsRNA also induces apoptosis
(King and Goodbourn, 1998). Thus dsRNA increases
production of immunomodulatory proteins that signal
to the immune system while simultaneously activating
antiviral proteins and inducing apoptosis to inhibit
viral replication and viral spread to surrounding tis-
sues.
It has been demonstrated that Marburg virus, another
member of the family Filoviridae, is capable of infecting
and replicating in human umbilical vein endothelial cells
(HUVECs) (Schnittler et al., 1993). Recently, we demon-
strated that EZ also infects, replicates, and produces
progeny virions in HUVECs nearly as well as it does in
Vero E6 cells, the cells used to grow stock virus (Har-
court et al., 1998). We found that induction of several
immunomodulatory genes by interferon (IFN), but not by
IL-1b, was suppressed by EZ infection. dsRNA induces
many of the same genes as IFN-a and IFN-g (Bandyo-
padhyay et al., 1995; Decker, 1992; Meegan and Marcus,
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1989) but also induces a number of other genes that are
not induced by IFN, including VCAM-1, E-selectin, IL-6,
and IL-1 (Yang et al., 1994, 1994). Although dsRNA in-
duces expression of IFN-b (King and Goodbourn, 1994;
Whiteside et al., 1992), many responses to dsRNA are
independent of IFN as demonstrated by (1) the synthetic
dsRNA polyinosinic acid:polycytidylic acid (PIC) is capa-
ble of inducing 29-59(A)N and ISG15 in IFN-a/b null cells
(Memet et al., 1991); (2) the major IFN-stimulated re-
sponse element (ISRE)-mediated signaling used by PIC
requires IRF-1 and STAT-1a but not the other compo-
nents needed for IFN-a signaling (Bandyopadhyay et al.,
1995); and (3) PIC can induce several IFN-a-inducible
genes in the presence of cycloheximide without activat-
ing ISGF-3 (Decker, 1992), the primary transcription acti-
vation complex activated on exposure to IFN-a. ISGF-3
does not require de novo protein synthesis for activation.
In this report, we demonstrate that gene induction by
dsRNA in HUVECs is dramatically suppressed by infec-
tion with EZ. This inhibition includes genes such as IL-6
and intercellular adhesion molecule (ICAM)-1, whose in-
duction by IL-1 in EZ-infected cells remains intact. In
addition, EZ infection itself does not induce these genes.
By incapacitating the ability of the cell to respond to
dsRNA, the cell is unable to mount a defense against the
virus itself, and its ability to signal to the immune system
via the induction of immunomodulatory genes is also
attenuated. Thus the suppression of dsRNA signaling
would play a role in the pathogenesis of disease by
contributing to the dramatic immunosuppression charac-
teristics found in fatal Ebola virus infections.
RESULTS
We previously demonstrated that MHC I induction by
both IFN-a and IFN-g is suppressed by infection with EZ.
To determine whether induction of MHC I by dsRNA is
suppressed by EZ, PIC was added to cells for the final
24 h of a 96-h infection, and expression of MHC I was
measured by flow cytometry. This time point was chosen
because the viral infection of the cells is established as
evidenced by high levels of virion RNA and protein (data
not shown) and by the log phase release of progeny
virions (Harcourt et al., 1998). PIC induced a 2- to 3-fold
increase in MHC I expression in mock-infected cells.
However, in EZ-infected PIC-treated cells, the levels of
MHC I expression were only ;20% of that in mock-
infected PIC-treated cells (Figs. 1A and 1B).
PIC is well recognized for its ability to induce expres-
sion of type I IFN (King and Goodbourn, 1994; Whiteside
et al., 1992). PIC also induces a number of genes that are
not induced by IFN, including the cytokine IL-6 (Doukas
et al., 1994). Figure 2 demonstrates that both PIC and
IL-1b induce high levels of IL-6 protein in mock-infected
cells, but this induction by PIC was nearly 90% attenu-
ated in EZ-infected cells. In contrast, IL-1b induced high
levels of IL-6 protein in both mock-infected and EZ-
infected cells. To determine whether the block in dsRNA
signaling was unique to EZ virus or merely a conse-
quence of infection with a negative-stranded RNA virus,
HUVECs were infected with measles virus, a negative-
stranded RNA virus belonging to the same viral order as
EZ (Griffin and Bellini, 1996). Like EZ, measles grows well
in HUVECs (Friedman et al., 1981), but unlike EZ, mea-
sles infection results in the induction of several immu-
nomodulatory genes (Dhib-Jalbut and Cowan, 1993; Har-
court et al., 1998). Infection with measles induced IL-6
secretion and enhanced responsiveness to PIC by 57%
(Fig. 2B). The preincubation with measles before PIC
treatment was less with measles than with EZ due to the
greater cytopathic effect of measles compared with EZ
on HUVECs (data not shown). Thus the block in PIC
signaling appears to be unique to EZ.
We examined the effect of EZ infection on gene induc-
tion at the mRNA level. Northern blot analysis demon-
strated that multiple mRNAs were induced to high levels
by PIC in the absence of infection with EZ. Infection with
EZ inhibited induction of all of these genes by .80% (Fig.
3). In contrast, infection with EZ did not suppress induc-
tion of IL-6 and ICAM-1 by IL-1b even though induction of
these genes by PIC was suppressed. Thus infection with
EZ blocked responses to PIC, whereas gene induction by
IL-1b was not inhibited. EZ glycoprotein (GP) gene open
reading frame mRNA was detected to verify that infection
was comparable in all groups.
Because responses to PIC, but not responses to IL-1b,
were inhibited, we asked whether transcription factors
activated by these inducers were inhibited during EZ
infection. PIC and IL-1b both activate the latent transcrip-
tion factor NF-kB (Collins et al., 1995; Offermann et al.,
1995). Gel shift analysis indicated that both PIC (100
mg/ml) and IL-1b activated NF-kB at similar levels in
cells either mock infected or EZ infected (Fig. 4). Mock-
infected and EZ-infected cells treated with 10 mg/ml PIC
also had equal levels of NF-kB activation (data not
shown).
Some responses to PIC occur in part through activation
of transcription factors that recognize and transactivate
through IFN-responsive sequences found in the regulatory
regions of DNA (Bandyopadhyay et al., 1995; Boehm et al.,
1997; Daly and Reich, 1993; Kalvakolanu and Borden, 1996).
Gel shift analysis was performed using both ISRE (Fig. 5A)
and GAS (Fig. 5B) sequences to investigate the effect of EZ
infection on the ability of PIC to induce binding to these
sequences. In mock-infected cells, PIC induced the forma-
tion of several protein–DNA complexes that specifically
bound to the ISRE DNA (Fig. 5A, lane 4, complexes A–E) or
GAS DNA (Fig. 5B, lane 4). Supershift analysis revealed that
the complex bound to the GAS probe consisted of STAT-1
(lane 5). Infection with EZ strongly inhibited the formation of
these PIC-induced complexes (Figs. 5A, lane 5, and 5B,
lanes 6 and 7).
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DISCUSSION
In this report, we demonstrate that infection with EZ
blocks gene induction by PIC, whereas responses to
IL-1b remain intact. PIC-induced protein binding to the
GAS and ISRE elements was inhibited in EZ-infected
cells, whereas activation of the latent transcription factor
NF-kB by both PIC and IL-1b was unaffected in EZ-
infected cells. This inhibition is dependent on live virus
because virus inactivated by g-irradiation is incapable of
disrupting gene induction by PIC (data not shown). In
addition, this observation is unique to EZ and not simply
a function of infection with a negative-stranded RNA
FIG. 1. Effect of EZ infection on MHC I protein induction by PIC. The levels of MHC I protein expression were measured by flow cytometric analysis
in HUVECs infected at an m.o.i. of 1.0 with EZ for 96 h and treated with 10 mg/ml PIC for the final 24 h of infection. (A) Histograms of MHC I induction.
(Top) Mock infection for 96 h with negative control (in gray). (Second from top) EZ infection for 96 h. (Second from bottom) Mock infection for 96 h
and treated with PIC for the final 24 h. (Bottom) EZ infection for 96 h followed by treatment with PIC for the final 24 h. The dotted line represents the
mean immunofluorescence in cells mock-infected for 96 h. Serum-free medium was used in mock infections in this and all other experiments. (B)
Graphic representation of two experiments as described in A. These histograms are representative of two experiments, except for EZ infection for
96 h with PIC treatment for the final 24 h, which was performed in triplicate. Control cells were not treated with PIC. Error bars are given as standard
deviation. The mean immunofluorescence is a relative number representing the fluorescence intensity of FITC presented on a linear scale.
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virus because measles virus, which also readily infects
HUVECs, enhanced the ability of PIC to induce IL-6
protein. The inhibition is not due to massive cell death in
the monolayer, and although cytopathic effect in the form
of cell-rounding is evident at the 96-h time point, the
monolayer is intact (data not shown) and is metabolically
active. 35S-Cysteine labeling experiments revealed that
there is a decrease in global cellular translation in EZ-
infected cells. However, this decrease is similar to the
decrease caused by treatment with PIC in the absence of
EZ infection (Harcourt et al., 1998). Because PIC is such
a potent gene inducer despite the decrease in global
protein translation, we reasoned that the decrease in
global translation in EZ-infected cells could not explain
the inhibition of gene induction. In addition, any change
in cell viability secondary to EZ infection was less than
that from measles, where responses to PIC were en-
hanced. We also found that there is a lag between when
cells are infected with EZ and when the inhibition occurs
because cells infected with EZ for 24 h have an intact
response to PIC (data not shown). This suggests that a
viral RNA or protein species or the induction of a cellular
gene is required for the inhibition.
We have shown previously that gene induction by IFN
is also blocked by infection with EZ (Harcourt et al.,
1998). The inhibition by EZ of gene induction by PIC is not
restricted to genes that can also be induced by IFNs
because IL-6 is not induced by either IFN-a or IFN-g,
whereas it is induced by IL-1b. Thus the inhibition of PIC
induction of IL-6 cannot be explained by the selective
block in IFN signaling seen previously. Furthermore, the
ability of EZ-infected cells to express IL-6 and ICAM-1 in
response to IL-1b, but not in response to PIC, indicates
that EZ is specifically inhibiting PIC signaling and not the
general transcriptional machinery for IL-6 and ICAM-1.
We found that mRNA induction by PIC for all of the
genes investigated was suppressed by EZ infection. The
mRNAs for IRF-1, 29-59(A)N, PKR, IL-6, and ICAM-1 were
barely detectable in response to PIC in EZ-infected cells.
Although MHC I mRNA levels in EZ-infected cells in-
creased in response to PIC, the increase was only 20% of
that observed in mock-infected cells treated with PIC
and was not associated with an increase in cell surface
protein. Cell surface levels of MHC I in EZ-infected cells
FIG. 3. Effect of infection with EZ on gene induction. HUVECs were
either mock or EZ infected at an m.o.i. of 1.0 for 72 h before treatment
with PIC or IL-1b for 24 h. Total cellular RNA (15 mg) was size fraction-
ated and analyzed by Northern blot analysis. All bands coincided with
the known size of the mRNA of each gene. The GAPDH probe con-
firmed similar RNA loading between lanes.
FIG. 2. Effect of infection with EZ and measles on IL-6 protein
induction. Conditioned medium was collected from HUVECs that had
been treated with either PIC or IL-1b (100 U/ml) for the final 24 h of
either a 96-h mock infection (solid bars) or EZ infection (stippled bars)
(A) or treated with PIC for the final 24 h of either a 48-h mock infection
(solid bars) or measles infection (stippled bars) (B). Both EZ and
measles were used at an m.o.i. of 1.0. The measles samples that were
not treated with PIC were harvested at a 24-h time point. Control cells
were not treated with PIC or IL-1b. IL-6 was measured by sandwich
ELISA. Mean 6 SD are given in pg/ml. Samples were done in duplicate.
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treated with PIC were less than in control cells, suggest-
ing that in addition to inhibiting the induction of MHC I,
EZ infection may also interfere with MHC I mRNA trans-
lation efficiency or MHC I processing.
Like IFN, dsRNA activates transcription factors that
bind and transactivate through the ISRE and GAS (Kumar
et al., 1997; Wong et al., 1997). We have observed that EZ
blocks IFN (Harcourt et al., 1998) and dsRNA induced
binding to these IFN-inducible gene regulatory elements,
suggesting that a component or components shared
between the IFN and dsRNA signaling pathways are
disrupted by infection with EZ. Studies using cell lines
genetically altered to lack IFN-a and components of the
IFN-a signaling pathway demonstrated that gene induc-
tion by PIC requires STAT-1a and the IFN-inducible tran-
scription factor IRF-1 (Bandyopadhyay et al., 1995). How-
ever, they did not investigate genes such as IL-6 that are
inducible by dsRNA but not by IFN. Thus the role of
STAT-1a and IRF-1 in response to PIC was established
only for genes known to be induced by either IFN or PIC.
STAT-1a is vital to gene induction by both IFN-a and
IFN-g (Darnell et al., 1994). It is possible that EZ infection
leads to the inhibition of STAT-1a function, which would
lead to the loss of signaling by both IFN-a and IFN-g and
possibly by dsRNA in HUVECs. In addition, we demon-
strated that PIC induction of IRF-1 is inhibited by infection
with EZ; therefore, it is possible that the lack of IRF-1 in
EZ-infected HUVECs could also play a role in the inhibi-
tion of gene induction by PIC. It has also been reported
that dsRNA can induce ISRE binding through a pathway
independent of the IFN signaling pathway (Decker, 1992;
Memet et al., 1991). The dsRNA factors (DRAFs) 1 and 2
have been found to bind ISRE sequences and are com-
pletely independent of the IFN signaling pathway (Daly
and Reich, 1993). dsRNA leads to the activation and DNA
binding activity of DRAF 1, which has recently been
shown to consist of the preexisting proteins IRF-3 and
the coactivator CBP/p300 (Weaver et al., 1998; Yoneyama
et al., 1998). If both of these signaling pathways are
active in HUVECs, it is possible that EZ has evolved a
means to inhibit both of these arms of the dsRNA sig-
naling pathway.
In addition to the factors described above, PIC, but not
IFN, induces genes in part through the activation of the
latent transcription factor NF-kB, possibly through the
activation of the dsRNA-activated protein kinase PKR
(Kumar et al., 1994). Workers at our laboratory have
shown that PIC induces immunomodulatory genes, acti-
vates NF-kB, and activates PKR in HUVECs (Offermann
et al., 1995). It has been demonstrated that the NF-kB
binding site is necessary to confer IL-1b responsiveness
to both the IL-6 (Merola et al., 1996) and ICAM-1 (Lede-
bur and Parks, 1995) genes. Infection with EZ had little
effect on ICAM-1 and IL-6 gene induction and NF-kB
activation by IL-1b but inhibited gene induction by PIC.
Because NF-kB activation by PIC remains intact in EZ-
infected cells, it is likely that gene induction by PIC may
require induced transcription factors in addition to NF-
kB. Alternative explanations include (1) a nontransacti-
vating species of NF-kB may be activated, (2) the time
course of NF-kB activation may be altered, (3) gene
induction may be occurring but the resulting RNA may be
highly unstable, or (4) PIC-activated NF-kB may be mod-
ified or rendered ineffective by EZ.
dsRNA, which is produced by RNA viruses during
gene transcription, during genomic replication, in mRNA
secondary structure, or a combination, enhances the
host antiviral response in two ways: (1) dsRNA induces
the expression of several immunomodulatory and antivi-
ral genes including, but not limited to, MHC I, IL-6,
ICAM-1, PKR, and 29-59(A)N; and (2) dsRNA activates the
antiviral proteins PKR and 29-59(A)N. MHC I, IL-6, and
ICAM-1 all play roles in the generation of a host immune
response, whereas PKR and 29-59(A)N are also involved
in cellular mechanisms of defense against viral replica-
tion. All of the genes mentioned above are not induced
FIG. 4. NF-kB activation by PIC and IL-1b occurs in EZ-infected cells.
HUVECs were either mock infected or EZ infected at an m.o.i. of 1.0 for
75 h and treated with PIC (100 mg/ml) or IL-1b for the final 3 h. Gel shift
analysis was performed on nuclear extracts from each condition using
the NF-kB binding site from the IL-6 promoter as a probe. NF-kB
represents the primary specific complex detected. Both the specific
(IL-6 NF-kB) and nonspecific competitor DNA (PRD I)2 were added in
30-fold excess and tested using a PIC 6-h sample. Binding complexes
were resolved by 4% nondenaturing polyacrylamide gel electrophore-
sis and visualized by autoradiography.
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by EZ infection itself and cannot be induced when exog-
enous dsRNA is added to EZ-infected cells. Furthermore,
the induction of MHC I, PKR, and 29-59(A)N by IFNs is also
blocked, whereas HUVECs remain responsive to IL-1b
(Harcourt et al., 1998). The consequences of inhibiting
the expression of these genes could be profound. MHC
1 is a surface protein that presents antigen to CD81
cytotoxic T cells (Germain, 1994), and reduced expres-
sion of MHC I in EZ-infected cells would affect the host’s
ability to mount a protective cytotoxic T cell-mediated
response. By inhibiting induction of IL-6, EZ is hampering
the host’s ability to generate a humoral response be-
cause IL-6 signals undifferentiated B cells to differentiate
into plasma cells, signals plasma cells to secrete anti-
body, and acts as a costimulator for T cells (Brach and
Herrmann, 1992). The cellular adhesion molecule
ICAM-1 is important to the inflammatory response
through the interaction between its counterreceptors
(LFA-1, Mac 1, or both) expressed on activated leuko-
cytes. This interaction regulates in part the tight adhe-
sion and transendothelial migration that lead to leuko-
cyte infiltration into an area of inflammation (Dustin and
Springer, 1988; Simmons et al., 1988). By inhibiting the
expression of this protein, the inflammatory response
may be somewhat attenuated. It is possible that other
dsRNA-induced cellular adhesion molecules not investi-
gated in this study are also similarly suppressed by EZ.
Both PKR and 29-59(A)N are antiviral proteins induced by
dsRNA and IFNs and activated by dsRNA. PKR is a
serine–threonine protein kinase expressed at low levels
constitutively in HUVECs, which, on activation, leads to
the inhibition of protein synthesis (Hovanessian, 1993)
and is thought to lead to the activation of the latent
transcription factor NF-kB through the phosphorylation of
its inhibitor, IkB (Kumar et al., 1994). It is possible that
PKR in part mediates dsRNA signaling through activation
of NF-kB. Activation of 29-59(A)N by dsRNA leads to viral
and cellular mRNA degradation through the latent ribo-
nuclease RNase L (Boehm et al., 1997). By suppressing
the induction of these two genes by either dsRNA or
FIG. 5. Effect of EZ infection on binding to the ISRE or GAS elements. HUVECs were either mock infected or EZ infected at an m.o.i. of 1.0 for 75 h
and treated with PIC for the final 3 h (A) and 6 h (B). Gel shift analysis was performed on nuclear extracts using either the ISRE element from the
ISG54 gene (A) or the GAS element from IRF-1 (B). Both the specific (ISG54 ISRE for A and IRF-1 GAS for B) and nonspecific competitor DNAs (IL-6
NF-kB site for A and the NF-kB site from the mouse k light chain gene in B) were added in 30-fold excess and tested using a mock/IFN-a sample
(A) or mock/PIC sample (B). Supershift analysis was performed with a monoclonal STAT-1a antibody. Binding complexes were resolved by 4%
nondenaturing polyacrylamide gel electrophoresis and visualized by autoradiography.
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IFNs, EZ would be subverting the cell’s ability to disrupt
viral replication and spread. It is possible that EZ, like
many other viruses, is inhibiting some or all PKR function.
Although many viruses have been shown to disrupt PKR
function (Jagus and Gray, 1994), it has not been deter-
mined whether viral inhibition of PKR has an effect on
PIC induction of immunomodulatory genes.
In conclusion, EZ not only fails to activate the dsRNA-
induced innate immune response but also blocks re-
sponses to exogenous dsRNA and to IFNs. Cells are
unable to recognize viral infection and are unable to
signal to the immune system during infection. The inhi-
bition of these genes would lead to unchecked viral
growth in endothelial cells, furthering the spread of the
virus to surrounding tissues. Furthermore, the inhibition
of these gene could play a part in the immunosuppres-
sion seen during Ebola virus infection and could play a
role in the pathogenesis of disease caused by infection
with Ebola virus.
MATERIALS AND METHODS
Cell culture and virus used
HUVECs were isolated from human umbilical veins
that were cannulated, perfused with Hanks’ solution to
remove blood, and then incubated with 1% collagenase
for 15 min at 37°C. After removal of collagenase, cells
were cultured in Medium 199 supplemented with 20%
FCS (GIBCO BRL Life Technologies, Gaithersburg, MD),
16 U/ml heparin (ESI Pharmaceuticals, Cherry Hill, NJ),
50 mg/ml endothelial cell growth supplement (ICN Bio-
medical, Irving, CA), 25 mM HEPES buffer, 2 mM
l-glutamine, 100 U/ml penicillin, and 100 U/ml streptomy-
cin and grown at 37°C on tissue culture plates coated
with 0.1% gelatin (Sigma Chemical, St. Louis, MO). Cells
were passaged at confluency by splitting 1:4. Cells were
used within the first seven passages.
The EZ (Mayinga) strain is a 1976 isolate from tissue
samples taken from a fatal case (Kiley et al., 1980). The
virus used in experiments was obtained from low-pas-
sage stock cultures in Vero E6 cells as previously de-
scribed (Sanchez and Kiley, 1987) and titered by plaque
assay. Plaque assays were performed using confluent
Vero E6 cells cultured in six-well plates. Cells were
infected in duplicate with serial 10-fold dilutions of virus.
Infection was done in an inoculum of 0.1 ml and allowed
to adsorb for 30 min at 37°C with 5% CO2. After absorp-
tion, 3 ml of Eagle’s basal medium containing 1% FBS
and 1% SeaKem agarose (FMC BioProducts, Rockland,
ME) was added to each well. After 5 days, 1 ml of neutral
red was added at a dilution of 1:20 in PBS. Plaques were
counted 2 days later.
The Moraten vaccine strain of measles virus (Attenu-
vax; Merck Sharp & Dohme, West Point, PA) was origi-
nally derived from a wild-type measles virus (Enders,
1954; Rota et al., 1994) and was propagated as previously
described (Harcourt et al., 1998).
HUVECs were infected in all experiments at an m.o.i.
of ;1.0. Infection was done with an inoculum of 2.0 ml of
serum-free Medium 199 that was allowed to adsorb for
30 min. After absorption, 13 ml of fully supplemented
Medium 199 was added. Serum-free medium was used
for mock infections in all experiments shown. All work
with live Ebola virus was performed in the maximum
containment laboratory at the Centers for Disease Con-
trol and Prevention (Atlanta, GA).
Reagents
IL-1b was from Boerhinger-Mannheim (Indianapolis,
IN), and PIC was from Pharmacia Biotech (Piscataway,
NJ).
Measurement of IL-6
IL-6 was measured either by using a standard sand-
wich ELISA kit according to the manufacturer’s instruc-
tions (PerSeptive Biosystems, Framingham, MA) (Fig. 2B)
or by the following protocol. Conditioned medium was
treated with Tween 20 to a final concentration of 1% and
then subjected to 1.2 3 106 rads of g-irradiation. This
percentage of detergent and g-irradiation is sufficient to
kill the virus without interfering with the ELISA assay. The
sandwich ELISA assay was performed by coating a 96-
well plate with 100 ml/well of 1 mg/ml IL-6 Pharm 18871D
rat anti-human IL-6 antibody (PharMingen, San Diego,
CA) diluted in coating buffer (carbonate pH 9.6) overnight
at 4°C. The plate then was coated with blocking solution
(PBS, 5% milk, and Tween 20 at 0.25%) for 1 h at 37°C.
Duplicate samples were added and incubated overnight
at 4°C. Pharm 20792D rat anti-human IL-6 biotinylated
detection antibody (1 mg/ml) (PharMingen) was added
and incubated for 1 h at 37°C. Then, 100 ml of strepa-
vidin–HRP conjugate (Amersham Life Science, Arlington
Heights, IL) was added at a 1:2500 dilution and incu-
bated for 2 h at room temperature. Binding of the HRP
conjugate was assessed by the addition of 100 ml of 0.1
mg/ml tetramethylbenzidine (Sigma Chemical) and 0.01%
H2O2. The reaction was stopped by the addition of 25 ml
of 8 N sulfuric acid, and the plates were read on a
BioRad model 450 ELISA Reader (Richmond, CA) at 450
nm. IL-6 levels were determined using a standard curve
ranging from 5000 to 78 pg/ml.
Flow cytometric analysis
HUVECs were rinsed twice with PBS and detached
using 1 ml of versene with gentle scraping. The cells
were then pelleted and resuspended in 0.5 ml of PBS
followed by the addition of 0.5 ml of 2% paraformalde-
hyde for 2 h at 4°C to inactivate the virus. Cells then were
pelleted, rinsed twice with cold PBS, and incubated for
30 min with constant shaking at 4°C with 20 ml of FITC-
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conjugated goat anti-human HLA-ABC antibody (Ancell
Corporation, Bayport, MN) diluted 1:50 in PBS or with
FITC-conjugated goat anti-mouse IgG. The cells were
resuspended in 0.5 ml of PBS and analyzed by flow
cytometry on a FACSort (Becton-Dickinson, San Jose,
CA).
RNA isolation and Northern blot analysis
Total cellular RNA was isolated using RNAsol (Cinna/
Biotecx Laboratories, Houston, TX). Cells were rinsed
with PBS and then lysed with RNAsol and processed
according to the manufacturer’s instructions. Total cellu-
lar RNA (15–20 mg) was size-fractionated using 1% aga-
rose formaldehyde gels in the presence of 1 mg/ml
ethidium bromide (Selden, 1987). The RNA was trans-
ferred to nitrocellulose (GIBCO BRL), covalently linked by
ultraviolet irradiation using a Stratalinker UV crosslinker
(Stratagene, La Jolla, CA), and then baked for 2 h at 80°C.
After a 4-h prehybridization in the absence of 32P-labeled
DNA or dextran, nitrocellulose was hybridized at 42°C
overnight in a solution containing 53 SSC, 1% SDS, 53
Denhardt’s Solution, 100 mg/ml salmon sperm DNA, 50%
formamide, 10% dextran sulfate, and ;100 ng of 32P-
dCTP DNA (ICN Biomedicals, Costa Mesa, CA) labeled
at a specific activity of $1 3 108 cpm/mg. DNA probes
were made using the random primer oligonucleotide
method with the Oligolabeling Kit from Pharmacia Bio-
tech. Blots were washed twice in 23 SSC/1% SDS for 30
min at 55°C and then once in 0.23 SSC/0.1% SDS for 30
min at 55°C. Autoradiography was performed with an
intensifying screen at 270°C. Blots were stripped using
boiling water before rehybridization with subsequent
probes. The ICAM-1 probe was a 1.8-kb EcoRI fragment
of human cDNA (Staunton et al., 1988). The IL-6 probe
was a 1.0-kb EcoRI fragment of the human cDNA excised
from clone pXM309 (Sutherland et al., 1988). The GAPDH
probe was a 1.2-kb EcoRI fragment of the human cDNA
excised from clone HHCMC32 (Adams et al., 1992). The
MHC I probe was a 6.0-kb EcoRI fragment of the human
genomic HLA-B7 gene. The IRF-1 probe was a 1.2-kb
NcoI–XbaI fragment of the human cDNA (Whiteside et al.,
1992). The 29-59(A)N probe was a 1.2-kb EcoRI fragment of
the human cDNA (Benech et al., 1985). The Ebola glyco-
protein gene open reading frame riboprobe was made as
previously described (Sanchez et al., 1993) using the
plasmid pGEM-EMGP2. Quantification was done by
PhosphorImager analysis using a BioRad PhosphorIm-
ager.
Electrophorectic mobility shift assays
Electrophorectic mobility shift assay analysis was per-
formed using ;3 mg of nuclear extract per lane as
previously described (Offermann et al., 1995; Zimring et
al., 1998). All probes consisted of blunt-ended, double-
stranded DNA generated by annealing synthetic oligode-
oxynucleotide primers (described below with binding
sites underlined) and radiolabeling with (a-32P)dCTP in
an extension reaction using Klenow as described previ-
ously (Zimring et al., 1998). The NF-kB binding probe
contains the NF-kB binding site from the IL-6 gene pro-
moter (Merola et al., 1996), 59-TATCAAATGTGGGATTTTC-
CCATGAGTCTCCAA-39, and the complementary primer
59-TTGAGACTCATGGGA-39. The ISRE probe was from
the ISRE sequence from the ISG54 gene promoter (Levy
et al., 1988): 59-AAAGGGAAAGTGAAACTAGA-39 and the
complementary primer 59-TCTAGTTTCA-39. The GAS
probe was from the GAS site in the IRF-1 gene promoter
(Rein et al., 1994): 59-CATCATTTCGGGGAAATCAGG-39
and the complementary primer 59-CCTGATTTC-39. DNA
containing the IL-6 NF-kB site, the NF-kB site from the
mouse immunoglobulin k light chain gene (Zabel et al.,
1991), or DNA-containing tandem PRDI sites (PRD I)2
from the IFNb promoter (Zimring et al., 1998) was used
as a nonspecific competitor in 30-fold excess, when
used.
Supershift analysis was done using 1.5 mg/sample of a
monoclonal antibody to the N-terminus of STAT-1 (Trans-
duction Laboratories, Lexington, KY).
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